IUCRO-0049; Immunological Genetic Molecular and pathological Correlates with Clinical and Treatment Outcome in Patients With Renal Cell Carcinoma
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Renal Cell Carcinoma
Age: Between 18 - 100 Years
Gender: Male or Female
Patients must have documented or suspected renal cell cancer.